Quture International Inc. (QUTR) 0.0020 $QUTR
Quture (QUTR) Announces New Chief Software Architect
Marketwire - Tue Jul 08, 9:15AM CDT
Quture International, Inc. (OTCQB: QUTR) ("Q"
the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability, today announced the addition of Ron Truxton of Boston, Massachusetts as the Chief Software Architect (CSA) to Q's Management Team. Extensive expertise and experience with the InterSystems strategic technology platform on which Q's QualOptima product is developed was a key determining factor in this strategic hire. A major milestone in Q's transition to revenue-based operations has now been successfully achieved in anticipation of commercialization and production of its product with intensifying marketing and sales and product installations.
Quture (QUTR) Announces QualOptima Go to Market Plan and Staffing for Installations of Sales to Existing & New Customers
Marketwire - Fri May 23, 12:15PM CDT
Quture International, Inc. (OTCQB: QUTR) ("Q" the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability, today announced successful completion of its Go to Market Plan for its QualOptima Versions 1 and 2 technology for installations and sales to existing and new customers. Q's extensive development of the QualOptima Connectivity & Analytics System for customer segments and value propositions, including embedded intellectual property, has resulted in potential sale of the full transformational software system for healthcare enterprise management in Version 2.0 at intended reference sites. The Marketing Plan for Version 2.0 focuses on the Clinical Trial at the University of Miami/Jackson Memorial Hospital. Initial marketing, sales and installations in process are for the previously announced Professional Practice Evaluation Application in Version 1 of QualOptima. Marketing and commercial sales are focused on five (5) versions of QualOptima, for software as a service (SaaS) or bundled with consulting through Q's subsidiary QualVal Solutions, LLC, to penetrate the estimated $2.5 billion market in the United States with intentions to expand globally through Q's subsidiary Quture Euro, LLC.
Quture Retains Martin Scott CFO Consulting to Prepare and File Forms 10-K and 10-Q With Securities & Exchange Commission
Marketwire - Wed May 21, 7:15AM CDT
Quture International, Inc. (OTCQB: QUTR) ("Q" today announced that after an extensive search, it has engaged Martin Scott CFO Consulting Services, Inc. to work with its legal counsel and auditor to prepare and file its Forms 10-K and 10-Q's as previously discussed in the Company's recent Shareholder Letter and Update. Pending any unforeseen delays, the Company is confident in its ability to file these items in the near future. As previously announced, the delay in filing has been to examine and take appropriate action regarding previously reported, undocumented debt in its previous merger with Techs Loanstar (trading as TCLN), as well as material changes in the condition of the Company and several affiliations in that merger.
Quture (QUTR) to Demonstrate Its Ready-to-Market Clinical Intelligence Software QualOptima V1 at HIMSS14 Conference
Marketwire - Fri Feb 21, 7:15AM CST
Quture International, Inc. (OTCQB: QUTR) (Q), the proven and experienced clinical performance and outcomes analytics and solutions company in American healthcare, today announced its plans to participate in the largest health IT industry event of the year, HIMSS Annual Conference & Exhibition, being held at the Orange County Convention Center in Orlando, Florida February 24 - 27, 2014. There Q will introduce for the first time its QualOptima product demonstration and be available at the InterSystems booth on the tradeshow floor at designated times, as well as participating in scheduled product presentations. In addition, Q will be meeting with healthcare providers, focusing on Information Technology (IT) executives in attendance, as well as other vendors to continue to pursue strategic alliances and channel distribution sales, throughout the conference.
Quture (QUTR) Receives Initial Funding for Proctoring Application to Expand QualOptima Software Product
Marketwire - Tue Feb 18, 7:15AM CST
Quture International, Inc. (OTCQB: QUTR) (Q) today announced receipt of the first tranche of funding for final development of the Proctoring Application of its QualOptima product. Projected for release in the summer of 2014, the Proctoring Application will again propel and differentiate Quture in first mover position to transition from peer review to clinical performance and outcomes measurement in the healthcare analytics market. Proctoring is required to determine current clinical performance for all physicians and clinical practitioners using performance analytics by the Joint Commission for hospital compliance with its accreditation standards. This is the third requirement of Focused and Ongoing Professional Practice Evaluation (FPPE-OPPE). When Q introduces this next application to electronically capture clinical performance and outcomes data, its software will be even further differentiated in this mandated market.
Quture (OTCQB: QUTR) Prepares for Intended Growth and Engages Windmill for Communication Design and Management Services Including Social Media
Marketwire - Wed Jan 29, 7:02AM CST
Quture International, Inc. (OTCQB: QUTR) ("Q" , the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability and intentions through its subsidiary Quture Euro, today announced that in preparation for intended growth ahead, the Company has engaged Windmill (www.choosewindmill.com), a comprehensive provider of communication design and management services to small companies, for its suite of services including social media. Q's communications strategies are designed to increase investor awareness and, simultaneously, market its clinical intelligence products and services to the total array of potential health and healthcare customers.
OTC Daily Alert Stock Watch - Quture International, Inc. (OTC: QUTR)
WorldStockWire - Sat Sep 07, 11:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Quture (QUTR) Announces Sales of QualOptima Product in Joint Sales with New Health Analytics
ACCESSWIRE - Mon Aug 12, 7:05AM CDT
Quture Announces Progress toward Transition to Revenue-Based Company by Sale of QualOptima Combined New Health Analytics Product in Joint Sales of Licenses
Quture (QUTR) Announces Sale of First Application of QualOptima Product
Marketwire - Thu Jun 06, 9:00AM CDT
Quture International, Inc. (OTCQB: QUTR) announced today a sale of the first application of the QualOptima product to Springhill Medical Center (SMC), Springhill, LA. The new license to QualOptima transitions SMC's former peer review product by Quture to performance measurement as the initial application of the QualOptima Analytics & Connectivity System on the InterSystems platform. The QualOptima System is the complete solution for "transformative and disruptive" technology to enhance clinical performance and achieve optimal patient outcomes. Quture announced on May 9, 2013 target marketing of QualOptima in June for commercial sales and installations. Quture is installing the QualOptima product and combined products of New Health Analytics, Richmond, VA. This sale demonstrates customer satisfaction to not only renew Quture's former product, but to replace it with the enhanced peer review tools to accomplish the requirements of clinical performance and outcomes measurement with the new QualOptima product. T
Quture (QUTR) Announces Commercial Release of First Application of QualOptima Product
Marketwire - Thu May 09, 9:00AM CDT
Quture International, Inc. (OTCQB: QUTR) announced today the launch of the first application of QualOptima for hospitals, physician groups, payers and regulators to transform peer review to clinical performance measurement and analytics. Commercial marketing and sales will begin in June for installations beginning in July. The technology for the cloud application of QualOptima is on the InterSystems platform now licensed by Quture. As previewed in the announcement on April 4, 2012, this initial QualOptima application is being launched following successful completion of the Clinical Trial at the University of Miami/Jackson Memorial Hospital (UoM) using the installation at Springhill Medical Center, Springhill, LA to test and evaluate the application's ROI and user advantages of this Connectivity & Analytics System. QualOptima is Quture's "transformative and disruptive" tool to enhance clinical performance to achieve optimal patient outcomes.
Quture (QUTR) and New Health Analytics Jointly Announce Joint Marketing & Sales Agreement
Marketwire - Tue Apr 16, 7:01AM CDT
Quture International, Inc. (OTCQB: QUTR) and SMA Informatics Partners LLC, doing business as New Health Analytics, an LLC organized under the laws of Virginia (NHA) (www.newhealthanalytics.com) today jointly announce successful completion of their Joint Marketing & Sales Agreement. The Parties intend to immediately pursue joint sale and installation of their integrated products for performance and outcomes analytics in three (3) customer sites to demonstrate the value proposition of their products individually and enhanced operating in tandem. Joint sales will be to existing and prospective customers of the Parties through joint licensing and end-user agreements. Terms of the joint sale of licensing were not disclosed but are substantial for the financial integrity and prospectively for both Quture and NHA.
Quture (QUTR) Announces Completion of Clinical Trial Data Collection at University of Miami/Jackson Memorial Hospital
Marketwire - Tue Apr 02, 2:07PM CDT
Quture International, Inc. (OTCQB: QUTR) announced today that real-time clinical data was recently collected for approximately 800 perioperative patients at the University of Miami/Jackson Memorial Hospital (UoM). Keith A. Candiotti, MD, and his physician and clinical team and information technology experts collaborated to complete the formal Clinical Trial with Quture under contract, strict protocol supervised by the Investigational Review Board (IRB) and assisted by InterSystems Corporation, Cambridge, MA.
Quture International, Inc. Announces Postponement of Scheduled Shareholder Conference Call
Marketwire - Tue Jan 22, 8:02AM CST
Quture International, Inc. (OTCQB: QUTR) announced today that they are postponing the previously scheduled shareholder conference call on Wednesday, January 23, 2013, at 4:15 p.m. Eastern Standard Time. The press of business and completion of pending accomplishments requires the full time and attention of Quture's Chairman and CEO, Landon Feazell, who was to host the call.
Quture International, Inc. Announces Shareholder Conference Call Hosted by Landon Feazell, Chairman and CEO
Marketwire - Tue Jan 15, 1:55PM CST
Quture International, Inc. (OTCQB: QUTR) announced today that they will conduct a shareholder conference call on Wednesday, January 23, 2013, at 4:15 p.m. Eastern Standard Time to provide a management update and strategic marketing and sales plan for 2013. Quture's Chairman and CEO, Landon Feazell, will host the call. Shareholders, prospective shareholders, analysts and other interested persons may access the call by dial in fifteen minutes before using one of the following numbers:
Quture (QUTR) Announces New Chief Software Architect
Marketwire - Tue Jul 08, 9:15AM CDT
Quture International, Inc. (OTCQB: QUTR) ("Q"
the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability, today announced the addition of Ron Truxton of Boston, Massachusetts as the Chief Software Architect (CSA) to Q's Management Team. Extensive expertise and experience with the InterSystems strategic technology platform on which Q's QualOptima product is developed was a key determining factor in this strategic hire. A major milestone in Q's transition to revenue-based operations has now been successfully achieved in anticipation of commercialization and production of its product with intensifying marketing and sales and product installations. Quture (QUTR) Announces QualOptima Go to Market Plan and Staffing for Installations of Sales to Existing & New Customers
Marketwire - Fri May 23, 12:15PM CDT
Quture International, Inc. (OTCQB: QUTR) ("Q"
the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability, today announced successful completion of its Go to Market Plan for its QualOptima Versions 1 and 2 technology for installations and sales to existing and new customers. Q's extensive development of the QualOptima Connectivity & Analytics System for customer segments and value propositions, including embedded intellectual property, has resulted in potential sale of the full transformational software system for healthcare enterprise management in Version 2.0 at intended reference sites. The Marketing Plan for Version 2.0 focuses on the Clinical Trial at the University of Miami/Jackson Memorial Hospital. Initial marketing, sales and installations in process are for the previously announced Professional Practice Evaluation Application in Version 1 of QualOptima. Marketing and commercial sales are focused on five (5) versions of QualOptima, for software as a service (SaaS) or bundled with consulting through Q's subsidiary QualVal Solutions, LLC, to penetrate the estimated $2.5 billion market in the United States with intentions to expand globally through Q's subsidiary Quture Euro, LLC. Quture Retains Martin Scott CFO Consulting to Prepare and File Forms 10-K and 10-Q With Securities & Exchange Commission
Marketwire - Wed May 21, 7:15AM CDT
Quture International, Inc. (OTCQB: QUTR) ("Q"
today announced that after an extensive search, it has engaged Martin Scott CFO Consulting Services, Inc. to work with its legal counsel and auditor to prepare and file its Forms 10-K and 10-Q's as previously discussed in the Company's recent Shareholder Letter and Update. Pending any unforeseen delays, the Company is confident in its ability to file these items in the near future. As previously announced, the delay in filing has been to examine and take appropriate action regarding previously reported, undocumented debt in its previous merger with Techs Loanstar (trading as TCLN), as well as material changes in the condition of the Company and several affiliations in that merger. Quture (QUTR) to Demonstrate Its Ready-to-Market Clinical Intelligence Software QualOptima V1 at HIMSS14 Conference
Marketwire - Fri Feb 21, 7:15AM CST
Quture International, Inc. (OTCQB: QUTR) (Q), the proven and experienced clinical performance and outcomes analytics and solutions company in American healthcare, today announced its plans to participate in the largest health IT industry event of the year, HIMSS Annual Conference & Exhibition, being held at the Orange County Convention Center in Orlando, Florida February 24 - 27, 2014. There Q will introduce for the first time its QualOptima product demonstration and be available at the InterSystems booth on the tradeshow floor at designated times, as well as participating in scheduled product presentations. In addition, Q will be meeting with healthcare providers, focusing on Information Technology (IT) executives in attendance, as well as other vendors to continue to pursue strategic alliances and channel distribution sales, throughout the conference.
Quture (QUTR) Receives Initial Funding for Proctoring Application to Expand QualOptima Software Product
Marketwire - Tue Feb 18, 7:15AM CST
Quture International, Inc. (OTCQB: QUTR) (Q) today announced receipt of the first tranche of funding for final development of the Proctoring Application of its QualOptima product. Projected for release in the summer of 2014, the Proctoring Application will again propel and differentiate Quture in first mover position to transition from peer review to clinical performance and outcomes measurement in the healthcare analytics market. Proctoring is required to determine current clinical performance for all physicians and clinical practitioners using performance analytics by the Joint Commission for hospital compliance with its accreditation standards. This is the third requirement of Focused and Ongoing Professional Practice Evaluation (FPPE-OPPE). When Q introduces this next application to electronically capture clinical performance and outcomes data, its software will be even further differentiated in this mandated market.
Quture (OTCQB: QUTR) Prepares for Intended Growth and Engages Windmill for Communication Design and Management Services Including Social Media
Marketwire - Wed Jan 29, 7:02AM CST
Quture International, Inc. (OTCQB: QUTR) ("Q"
, the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability and intentions through its subsidiary Quture Euro, today announced that in preparation for intended growth ahead, the Company has engaged Windmill (www.choosewindmill.com), a comprehensive provider of communication design and management services to small companies, for its suite of services including social media. Q's communications strategies are designed to increase investor awareness and, simultaneously, market its clinical intelligence products and services to the total array of potential health and healthcare customers. OTC Daily Alert Stock Watch - Quture International, Inc. (OTC: QUTR)
WorldStockWire - Sat Sep 07, 11:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Quture (QUTR) Announces Sales of QualOptima Product in Joint Sales with New Health Analytics
ACCESSWIRE - Mon Aug 12, 7:05AM CDT
Quture Announces Progress toward Transition to Revenue-Based Company by Sale of QualOptima Combined New Health Analytics Product in Joint Sales of Licenses
Quture (QUTR) Announces Sale of First Application of QualOptima Product
Marketwire - Thu Jun 06, 9:00AM CDT
Quture International, Inc. (OTCQB: QUTR) announced today a sale of the first application of the QualOptima product to Springhill Medical Center (SMC), Springhill, LA. The new license to QualOptima transitions SMC's former peer review product by Quture to performance measurement as the initial application of the QualOptima Analytics & Connectivity System on the InterSystems platform. The QualOptima System is the complete solution for "transformative and disruptive" technology to enhance clinical performance and achieve optimal patient outcomes. Quture announced on May 9, 2013 target marketing of QualOptima in June for commercial sales and installations. Quture is installing the QualOptima product and combined products of New Health Analytics, Richmond, VA. This sale demonstrates customer satisfaction to not only renew Quture's former product, but to replace it with the enhanced peer review tools to accomplish the requirements of clinical performance and outcomes measurement with the new QualOptima product. T
Quture (QUTR) Announces Commercial Release of First Application of QualOptima Product
Marketwire - Thu May 09, 9:00AM CDT
Quture International, Inc. (OTCQB: QUTR) announced today the launch of the first application of QualOptima for hospitals, physician groups, payers and regulators to transform peer review to clinical performance measurement and analytics. Commercial marketing and sales will begin in June for installations beginning in July. The technology for the cloud application of QualOptima is on the InterSystems platform now licensed by Quture. As previewed in the announcement on April 4, 2012, this initial QualOptima application is being launched following successful completion of the Clinical Trial at the University of Miami/Jackson Memorial Hospital (UoM) using the installation at Springhill Medical Center, Springhill, LA to test and evaluate the application's ROI and user advantages of this Connectivity & Analytics System. QualOptima is Quture's "transformative and disruptive" tool to enhance clinical performance to achieve optimal patient outcomes.
Quture (QUTR) and New Health Analytics Jointly Announce Joint Marketing & Sales Agreement
Marketwire - Tue Apr 16, 7:01AM CDT
Quture International, Inc. (OTCQB: QUTR) and SMA Informatics Partners LLC, doing business as New Health Analytics, an LLC organized under the laws of Virginia (NHA) (www.newhealthanalytics.com) today jointly announce successful completion of their Joint Marketing & Sales Agreement. The Parties intend to immediately pursue joint sale and installation of their integrated products for performance and outcomes analytics in three (3) customer sites to demonstrate the value proposition of their products individually and enhanced operating in tandem. Joint sales will be to existing and prospective customers of the Parties through joint licensing and end-user agreements. Terms of the joint sale of licensing were not disclosed but are substantial for the financial integrity and prospectively for both Quture and NHA.
Quture (QUTR) Announces Completion of Clinical Trial Data Collection at University of Miami/Jackson Memorial Hospital
Marketwire - Tue Apr 02, 2:07PM CDT
Quture International, Inc. (OTCQB: QUTR) announced today that real-time clinical data was recently collected for approximately 800 perioperative patients at the University of Miami/Jackson Memorial Hospital (UoM). Keith A. Candiotti, MD, and his physician and clinical team and information technology experts collaborated to complete the formal Clinical Trial with Quture under contract, strict protocol supervised by the Investigational Review Board (IRB) and assisted by InterSystems Corporation, Cambridge, MA.
Quture International, Inc. Announces Postponement of Scheduled Shareholder Conference Call
Marketwire - Tue Jan 22, 8:02AM CST
Quture International, Inc. (OTCQB: QUTR) announced today that they are postponing the previously scheduled shareholder conference call on Wednesday, January 23, 2013, at 4:15 p.m. Eastern Standard Time. The press of business and completion of pending accomplishments requires the full time and attention of Quture's Chairman and CEO, Landon Feazell, who was to host the call.
Quture International, Inc. Announces Shareholder Conference Call Hosted by Landon Feazell, Chairman and CEO
Marketwire - Tue Jan 15, 1:55PM CST
Quture International, Inc. (OTCQB: QUTR) announced today that they will conduct a shareholder conference call on Wednesday, January 23, 2013, at 4:15 p.m. Eastern Standard Time to provide a management update and strategic marketing and sales plan for 2013. Quture's Chairman and CEO, Landon Feazell, will host the call. Shareholders, prospective shareholders, analysts and other interested persons may access the call by dial in fifteen minutes before using one of the following numbers:
